|
Respiratory system
/ Airways disease, obstructive
|
| |
fluticasone |
|
|
| |
Pressurised inhalation |
|
Flixotide Evohaler (GlaxoSmithKline UK Ltd)
|
Non-Formulary (or under review)
|
| |
Inhalation powder |
|
Flixotide Accuhaler (GlaxoSmithKline UK Ltd)
|
Formulary
|
|
Respiratory system
/ Respiratory depression, respiratory distress syndrome and apnoea
|
| |
poractant alfa |
Specialist Initiated for Hospital use Only
|
|
|
Respiratory system
/ Neonatal apnoea
|
| |
caffeine citrate |
|
|
| |
Oral solution |
|
Caffeine citrate (Non-proprietary)
|
Non-Formulary (or under review)
|
| |
Solution for infusion |
|
Caffeine citrate (Non-proprietary)
|
Non-Formulary (or under review)
|